Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
HIV/AIDS Resource Center for Women
Michelle Lopez Alora Gale Precious Jackson Nina Martinez Gracia Violeta Ross Quiroga Loreen Willenberg  
Michelle Alora Precious Nina Gracia Loreen  
The Feminization of an Epidemic

July/August 2009

 < Prev  |  1  |  2  |  3 

References

  1. Pardo M, Ruiz M, Gimeno A, et al. Gender bias in clinical trials of AIDS drugs. In: XIV International AIDS Conference. Barcelona, 2002
  2. Collins E, Walmsley S. Research on women, are we doing enough? XVII International AIDS Conference, Mexico City, Abstract# CDD0248, 2008
  3. Centers for Disease Control and Prevention (CDC). Cases of HIV and AIDS in the US. www.cdc.gov/hiv/topics/women/resources.htm (accessed 5/26/09), 2007
  4. Centers for Disease Control and Prevention (CDC). Leading Causes of Death in Females and Males in the United States. Women: www.cdc.gov/Women/lcod.htm; Men: www.cdc.gov/Men/lcod.htm Accessed 5/26/09
  5. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. Epidemiology 1998;9:117-125
  6. Hader SL, Smith DK, Moore JS and Holmberg SD. HIV infection in women in the United States: status at the Millennium. Jama 2001;285:1186-92
  7. Wolitski RJ, Jones KT, Wasserman JL and Smith JC. Self-identification as "down low" among men who have sex with men (MSM) from 12 US cities. AIDS Behav 2006;10:519-29
  8. Bond L, Wheeler DP, Millett GA, LaPollo AB, Carson LF and Liau A. Black men who have sex with men and the association of down-low identity with HIV risk behavior. Am J Public Health 2009;99 Suppl 1:S92-5
  9. Marks G, Crepaz N and Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. Aids 2006;20:1447-50
  10. Heyman KM, al. e. 2007 National Health Interview Study. CDC. National Center for Health Statistics 2008
  11. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55:1-17; quiz CE1-4
  12. Royce RA, Sena A, Cates W, Jr. and Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8
  13. Wira CR, Fahey JV. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. Aids 2008;22:1909-17
  14. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007;370:251-61
  15. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F and Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis 2002;35:313-22.
  16. Melnick S, Sherer R, Louis T, et al. Survival and disease progression according to gender of patients with HIV infection: the Terry Beirn Community Programs for Clinical Research on AIDS. J Am Med Assoc 1994;272:1915-1921
  17. Cozzi Lepri A, Pezzotti P, Dorrucci M, Phillips A and Rezza G. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study [Bmj 1994;309:1537-42]
  18. Collazos J, Asensi V and Carton JA. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. Aids 2007;21:835-43
  19. Gandhi M, Aweeka F, Greenblatt RM and Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 2004;44:499-523
  20. Nicastri E, Leone S, Angeletti C, et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother 2007;60:724-32
  21. Mazhude C, Jones S, Murad S, Taylor C and Easterbrook P. Female sex but not ethnicity is a strong predictor of non-nucleoside reverse transcriptase inhibitor-induced rash. AIDS 2002;16:1566-8
  22. Bersoff-Matcha SJ, Miller WC, Aberg JA, et al. Sex differences in nevirapine rash. Clin Infect Dis 2001;32:124-9
  23. Ananworanich J, Moor Z, Siangphoe U, et al. Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs. Aids 2005;19:185-92
  24. Madruga JV, Cahn P, Grinsztejn B, et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial. Lancet 2007;370:29-38
  25. Nevirapine package insert. Boehringer Ingelheim Pharmaceuticals, Inc. Copyright 2008
  26. Sanne I, Mommeja-Marin H, Hinkle J, et al. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects. J Infect Dis 2005;191:825-9
  27. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. Aids 2006;20:2165-74
  28. Fausto A, Bongiovanni M, Cicconi P, et al. Potential predictive factors of osteoporosis in HIV-positive subjects. Bone 2006;38:893-7
  29. Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr 2005;38:213-8
 < Prev  |  1  |  2  |  3 


This article was provided by Positively Aware. It is a part of the publication Positively Aware. Visit Positively Aware's website to find out more about the publication.
 
See Also
More on Women and HIV/AIDS

Reader Comments:

Comment by: Kristie (Superior, WI) Fri., Jun. 11, 2010 at 12:39 pm EDT
Just a quick clarification:

This article mentions that the female condom is not covert because the latex can be seen covering the outer female genitalia. The female condom is not latex - it is made from polyurethane. Partners with latex allergies can use the female condom - another bonus for its use.
Reply to this comment


Comment by: Cathy (Denver) Mon., Aug. 31, 2009 at 6:48 pm EDT
Would love to see an article on woman and menapause and HIV drugs and the affect they have with Hormone Replacement therapy.
Reply to this comment


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:



Copyright © 2007-2014 Remedy Health Media, LLC. All rights reserved.
Advertisement
See Also
Newly Diagnosed? Words of Encouragement from HIV-Positive Women
What Did You Expect While You Were Expecting?
HIV Tools You Can Use